Global InformationEurogentec information
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
 | |
| Company type | Private company |
|---|---|
| Industry | Biotechnology |
| Founded | 1985 |
| Headquarters | Seraing, Liège, Belgium |
Key people | Lieven Janssens, CEO |
| Products | Proteins, plasmids, vaccines, Oligonucleotides, qPCR Reagents, Antibodies, Peptides and Fluorophores Dyes & Quenchers |
Number of employees | > 400 (2022) |
| Website | www.eurogentec.com |
Eurogentec is a biotechnology supplier, based in Belgium, that specializes in genomics and proteomics kits, reagents, and certain biologics. It was founded in 1985 as a spin-off from the University of Liège.[1] Eurogentec operates two licensed contract manufacturing organization facilities in Belgium which produce custom biologic and oligonucleotide products mainly for European pharmaceutical companies, but also holds a license from the U.S. FDA to export a commercial protein product to the U.S.. These products are used to diagnose and treat various conditions. [2]
- ^ Clément Violet. "Eurogentec: Maturity Doesn't Stop Growth" (PDF). Wallonia-Brussels International. pp. 17–18. Archived from the original (PDF) on 2 September 2011.
- ^ "Eurogentec Biologics – Experience true partnership". Pharmatching. Retrieved 16 May 2011.
{{cite web}}: CS1 maint: url-status (link)